Diagnos Laboratorium Utama Tbk. vs Ekadharma International Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Ekadharma International Tbk. trades at Rp326 (market cap 1.05T, 82.72M 24h volume). The key difference: Ekadharma International Tbk. is far larger — about 3.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Ekadharma International Tbk. is more actively traded (82.72M versus 7.6K). Which is the better fit depends on your goals.
| DGNS | EKAD | |
|---|---|---|
Market Cap | 319B | 1.05T |
Volume | 7.6K | 82.72M |
Lot | 76 | 827.23K |
Turnover | 1.74M | 27.99B |
Average Price | 229.21 | 338.37 |
Value | 1.74M | 27.99B |
Indicative Equilibrium Price | 232 | 330 |
Indicative Equilibrium Volume | 200 | 24.68K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Ekadharma International Tbk (the Company) was established under the name of PT Ekadharma Widya Graphika based on Notarial Deed No. 71 dated November 20, 1981. PT Ekadharma Tape Industries Tbk manufactures computer continuous form paper and other related products. It also holds a manufacturing and distribution license from Nashua Corporation, USA.In August 2, 2006, The company's name was changed to PT Ekadharma International Tbk.
Read more on EKAD →